Company Overview and News

 
TORM acquires three new MR vessels

2018-04-03 globenewswire
TORM acquires three new MR vessels "We are pleased to expand the fleet with the addition of three MR newbuildings. The vessels are attractively priced when comparing to the current market, and we believe that now is an attractive time to secure new fuel-efficient tonnage that is compliant with the ballast water convention and ready for the IMO 2020 sulfur requirements," says Executive Director Jacob Meldgaard and continues: "The vessels are already fully funded by our USD 100m equity raise in January 2018 and through loan commitments from KfW and ABN AMRO.

 
TORM køber tre nye MR-skibe

2018-04-03 globenewswire
"Vi er glade for at kunne udvide vores flåde med tre MR-nybygninger. Prisen på skibene er attraktiv, når vi sammenligner med den nuværende markedspris, og vi mener, at det er et fornuftigt tidspunkt at sikre ny brændstofbesparende tonnage, der lever op til ballastvandkonventionen og er klargjort til IMO's svovludledningskrav i 2020," siger Executive Director Jacob Meldgaard og fortsætter: "Skibene er allerede fuldt finansierede via vores USD 100 mio.

 
Fortescue’s latest ore carrier arrives in Port Hedland

2018-02-26 australianmining.com.au
Fortescue Metals Group has welcomed the newest addition to its iron ore carrier fleet — FMG David.

 
Fortescue welcomes fifth ore carrier to Port Hedland

2018-01-03 australianmining.com.au
FMG Matilda, which follows on from FMG Nicola, FMG Grace, FMG Sophia and FMG Sydney, was welcomed last week by the Forrest family.

 
Fully electric cargo ship launched in Guangzhou

2017-11-14 technology.inquirer.net
Two technicians pass by the world’s first 2,000-metric-ton all-electric cargo ship during its debut in Guangzhou, capital city of Guangdong province. The ship can run 80 kilometers after being fully charged. XIA SHIYAN/CHINA DAILY

 
[Press] Global Maritime Completes Suitability Survey for World’s Second Largest Semi-Submersible

2017-02-12 oilvoice
Shanghai, China, February 10 2017: Global Maritime Consultancy & Engineering, a leading provider of offshore marine warranty, dynamic positioning and engineering services, has completed a suitability survey for the world's second largest semi-submersible - the ‘Xin Guang Hua' - in advance of her maiden voyage. For the survey, Global Maritime carried out an independent assessment of all aspects of the vessel's condition.

 
Global Maritime completes suitability survey for world’s second-largest semisubmersible

2017-02-10 worldoil
SHANGHAI, China -- Global Maritime Consultancy & Engineering, a provider of offshore marine warranty, dynamic positioning and engineering services, has completed a suitability survey for the world’s second largest semisubmersible, the Xin Guang Hua, in advance of her maiden voyage. For the survey, Global Maritime carried out an independent assessment of all aspects of the vessel’s condition.

 
China's carrier replenishment ship begins sea trials

2016-12-30 janes
The People's Liberation Army Navy's (PLAN's) new Type 901 replenishment ship commenced sea trials on 18 December, according to Chinese media.

 
FMG’s supersized iron ore vessel arrives

2016-12-19 perthnow.com.au
FORTESCUE Metal Group’s first Very Large Ore Carrier, named after Andrew Forrest’s wife, has arrived in Port Hedland after its maiden voyage from China. 

 
UPDATE: PLAN invests in new training ships

2016-10-18 janes
China's People's Liberation Army Navy (PLAN) appears to be investing in new training capability, according to images posted online.

 
PLAN invests in new training ships

2016-10-14 janes
China's People's Liberation Army Navy (PLAN) appears to be investing in new training capability, according to images posted online.

 
Navig8 Product Tankers Inc. Reports Results for the Three and Six Months Ended June 30, 2016

2016-08-03 prnewswire
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN OR INTO THE UNITED STATES (INCLUDING ITS TERRITORIES AND THE DISTRICT OF COLUMBIA) OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL

 
Navig8 Product Tankers Inc. Takes Delivery of Its Second Newbuilding Product Tanker From CSSC Offshore & Marine Engineering (Group) Company Limited

2016-07-05 marketwired
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN OR INTO THE UNITED STATES (INCLUDING ITS TERRITORIES AND THE DISTRICT OF COLUMBIA) OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL

 
Navig8 Product Tankers Inc. Takes Delivery of Its First Newbuilding Product Tanker From CSSC Offshore & Marine Engineering (Group) Company Limited

2016-05-23 marketwired
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN OR INTO THE UNITED STATES (INCLUDING ITS TERRITORIES AND THE DISTRICT OF COLUMBIA) OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL

 
Navig8 Product Tankers Inc. Reports Results for the Three and Twelve Months Ended December 31, 2015

2016-02-11 marketwired
LONDON, UNITED KINGDOM--(Marketwired - Feb 11, 2016) - Navig8 Product Tankers Inc. (the "Company") (N-OTC: EIGHT), an international shipping company focused on the transportation of petroleum products, today announced its unaudited financial and operating results for the three and twelve months ended December 31, 2015. Highlights Reported revenue of $9.1...

Related Articles

SGMO: Sangamo BioSciences and Research Report

2018-05-19 - Asif

OVERVIEW Sangamo BioSciences is a clinical stage biotechnology company focused on translating ground-breaking science into genomic therapies that transform patients’ lives using its industry-leading platform technologies in genome editing, gene therapy, gene regulation and cell therapy. Sangamo BioSciences is a leader in the research and development of zinc finger proteins, or ZFPs, a naturally occurring class of proteins found in humans. Sangamo BioSciences has used its knowledge and expertise to develop a proprietary technology platform in both genome editing and gene regulation. ZFPs can be engineered to make zinc finger nucleases, or ZFNs, proteins that can be used to specifically modify DNA sequences by adding or knocking out specific genes, or genome editing, and ZFP transcription factors or ZFP TFs, proteins that can be used to increase or decrease gene expression, or gene regulation. In the process of developing this platform, Sangamo BioSciences has accrued signific...

HMNY: Helios and Matheson Analytics and Research Report

2018-05-19 - Asif

Business Overview The company provide high quality information technology, or IT, services and solutions including a range of technology platforms focusing on big data, business intelligence, and consumer-centric technology. More recently, to provide greater value to stockholders, the Company has sought to expand its business primarily through acquisitions that leverage its capabilities and expertise. As of March 31, 2018, the Company owned 81.2%, and as of the date of this report the Company owns 91.8%, of the outstanding shares of MoviePass (excluding outstanding MoviePass options and warrants). MoviePass is the premiere movie theater subscription service in the United States which provides its subscribers the ability to view up to one new movie title per day for one monthly subscription price. The company's more than 2 million subscribers have access to see films in over 91% of U.S movie theaters. By the end of April 2018, the company implemented certain measures ...

BSTG: Biostage Analysis and Research Report

2018-05-17 - Asif

Overview Biostage is a biotechnology company developing bioengineered organ implants based on its novel CellframeTM technology. The company's Cellframe technology is comprised of a biocompatible scaffold that is seeded with the recipient’s own stem cells. This technology is being developed to treat life-threatening conditions of the esophagus, trachea or bronchus with the objective of dramatically improving the treatment paradigm for those patients. The company believe that its Cellframe technology will provide surgeons with new ways to address damage to the esophagus, bronchus, and trachea due to congenital abnormalities, cancer, infection or trauma. Products being developed based on its Cellframe technology for those indications are called CellspanTM products. The company announced favorable preliminary pre-clinical results of large-animal studies for the esophagus, trachea and bronchus in November 2015. Since then, the Cellspan esophageal implant product candidates hav...